Expert Opinion On Pharmacotherapy

雜志介紹

Expert Opinion On Pharmacotherapy雜志介紹

《Expert Opinion On Pharmacotherapy》是一本以English為主的未開放獲取國際優秀期刊，中文名稱藥物治療專家意見，本刊主要出版、報道醫學-PHARMACOLOGY & PHARMACY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.5，最新CiteScore 指數為5.6。

本刊近期中國學者發表的論文主要有：

• An evaluation of sodium zirconium cyclosilicate: a new treatment option for hyperkalaemia in China

  Author: Lu, Yuan; Liu, Bi-Cheng; Liu, Hong

• Emerging sodium-glucose cotransporter-2 inhibitor therapies for managing heart failure in patients with chronic kidney disease

  Author: Chan, Jeffrey Shi Kai; Perone, Francesco; Bayatpoor, Yasmin; Tse, Gary; Harky, Amer

• The correlations between steady-state concentration, duration of action and molecular weight of GLP-1RAs and their efficacy and gastrointestinal side effects in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

  Author: Jiao, Ruoyang; Lin, Chu; Bai, Shuzhen; Cai, Xiaoling; Hu, Suiyuan; Lv, Fang; Yang, Wenjia; Zhu, Xingyun; Ji, Linong

• Efficacy and safety of thrombopoietin receptor agonists in children and adults with persistent and chronic immune thrombocytopenia: a meta-analysis

  Author: Li, Ting; Liu, Qinqin; Pu, Ting; Liu, Jing; Zhang, Aijun

英文介紹

Expert Opinion On Pharmacotherapy雜志英文介紹

Expert Opinion on Pharmacotherapy is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on newly approved/near to launch compounds mainly of chemical/synthetic origin, providing expert opinion on the likely impact of these new agents on existing pharmacotherapy of specific diseases.